Tech Company Financing Transactions
Axena Health Funding Round
On 2/20/2023, Axena Health announced $25 million in Series A funding from AXA Investment Managers.
Transaction Overview
Company Name
Announced On
2/20/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
AXA Investment Managers (Lead Investor)
Proceeds Purpose
Axena offers the Leva Pelvic Health System, a prescription digital therapeutic aimed at treating urinary incontinence and chronic fecal incontinence in women.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
263 Summer Street
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia's technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women's health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eileen Maus
Browse more venture capital transactions:
Prev: 2/20/2023: Quell venture capital transaction
Next: 2/20/2023: Pliant venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs